5 WallStreetBets Stocks Gaining in August

3. Bionano Genomics, Inc. (NASDAQ:BNGO)

Number of Hedge Fund Holders: 6

Share Price Gain in the Last Month as of August 12: 130.77%

Bionano Genomics, Inc. (NASDAQ:BNGO) is a California-based company that offers genome analysis software solutions. The stock has climbed a whopping 131% in the last month as of August 12. Retail investors have been piling into Bionano Genomics, Inc. (NASDAQ:BNGO) lately, and the WallStreetBets community is abuzz with gains from this trade. On August 11, the stock jumped 36% on the back of a published study regarding the use of optical genome mapping offered by Bionano Genomics, Inc. (NASDAQ:BNGO) in the analysis of certain genetically-driven disorders.

On July 18, Oppenheimer analyst Francois Brisebois assumed coverage of Bionano Genomics, Inc. (NASDAQ:BNGO) with an Outperform rating and a $12 price target given a reallocation of the firm’s analyst resources.

According to Insider Monkey’s Q1 data, Bionano Genomics, Inc. (NASDAQ:BNGO) was part of 6 hedge fund portfolios at the end of Q1 2022, compared to 11 funds in the prior quarter. Ken Griffin’s Citadel Investment Group is the leading position holder in the company, with 772,362 shares worth about $2 million.